These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

302 related articles for article (PubMed ID: 33384663)

  • 1. Clinical Epigenetics of Neuroendocrine Tumors: The Road Ahead.
    Colao A; de Nigris F; Modica R; Napoli C
    Front Endocrinol (Lausanne); 2020; 11():604341. PubMed ID: 33384663
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Gastroenteropancreatic neuroendocrine tumors: Epigenetic landscape and clinical implications.
    McMurry HS; Rivero JD; Chen EY; Kardosh A; Lopez CD; Pegna GJ
    Curr Probl Cancer; 2024 Oct; 52():101131. PubMed ID: 39173542
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neuroendocrine tumours: cracking the epigenetic code.
    Karpathakis A; Dibra H; Thirlwell C
    Endocr Relat Cancer; 2013 Jun; 20(3):R65-82. PubMed ID: 23429748
    [TBL] [Abstract][Full Text] [Related]  

  • 4. NETs: organ-related epigenetic derangements and potential clinical applications.
    Cives M; Simone V; Rizzo FM; Silvestris F
    Oncotarget; 2016 Aug; 7(35):57414-57429. PubMed ID: 27418145
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The epigenetic and transcriptional landscape of neuroendocrine prostate cancer.
    Davies A; Zoubeidi A; Selth LA
    Endocr Relat Cancer; 2020 Feb; 27(2):R35-R50. PubMed ID: 31804971
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Epigenetic regulation of somatostatin and somatostatin receptors in neuroendocrine tumors and other types of cancer.
    Klomp MJ; Dalm SU; de Jong M; Feelders RA; Hofland J; Hofland LJ
    Rev Endocr Metab Disord; 2021 Sep; 22(3):495-510. PubMed ID: 33085037
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Genetics and Epigenetics of Pancreatic Neuroendocrine Tumors and Pulmonary Carcinoids.
    Dreijerink KM; Derks JL; Cataldo I; Scarpa A; Valk GD; Speel EJ
    Front Horm Res; 2015; 44():115-38. PubMed ID: 26303708
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Gastroenteropancreatic endocrine tumors.
    Meeker A; Heaphy C
    Mol Cell Endocrinol; 2014 Apr; 386(1-2):101-20. PubMed ID: 23906538
    [TBL] [Abstract][Full Text] [Related]  

  • 9. DNA methylation profiles distinguish different subtypes of gastroenteropancreatic neuroendocrine tumors.
    How-Kit A; Dejeux E; Dousset B; Renault V; Baudry M; Terris B; Tost J
    Epigenomics; 2015; 7(8):1245-58. PubMed ID: 26360914
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Genetic and epigenetic prognosticators of neuroendocrine tumours of the GI tract, liver, biliary tract and pancreas: A systematic review and meta-analysis.
    Mestre-Alagarda C; Srirajaskanthan R; Zen Y; Giwa M; Howard M; Ooft ML
    Histopathology; 2024 Jan; 84(2):255-265. PubMed ID: 37565289
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Genetics and Epigenetics of Gastroenteropancreatic Neuroendocrine Neoplasms.
    Mafficini A; Scarpa A
    Endocr Rev; 2019 Apr; 40(2):506-536. PubMed ID: 30657883
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Other Novel Therapies: Biomarkers, microRNAs and microRNA Inhibitors, DNA Methylation, Epigenetics, Immunotherapy and Virotherapy.
    Giandomenico V; Thirlwell C; Essand M
    Front Horm Res; 2015; 44():248-62. PubMed ID: 26303717
    [TBL] [Abstract][Full Text] [Related]  

  • 13. DNA Methylation of Tumor Suppressor Genes in Pituitary Neuroendocrine Tumors.
    García-Martínez A; Sottile J; Sánchez-Tejada L; Fajardo C; Cámara R; Lamas C; Barberá VM; Picó A
    J Clin Endocrinol Metab; 2019 Apr; 104(4):1272-1282. PubMed ID: 30423170
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Epigenetic regulation of SST
    Klomp MJ; Refardt J; van Koetsveld PM; Campana C; Dalm SU; Dogan F; van Velthuysen MF; Feelders RA; de Herder WW; Hofland J; Hofland LJ
    Front Endocrinol (Lausanne); 2023; 14():1184436. PubMed ID: 37223009
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Genetics and epigenetics in small intestinal neuroendocrine tumours.
    Stålberg P; Westin G; Thirlwell C
    J Intern Med; 2016 Dec; 280(6):584-594. PubMed ID: 27306880
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Advances in the systemic treatment of neuroendocrine tumors in the era of molecular therapy.
    Leung R; Lang B; Wong H; Chiu J; Yat WK; Shek T; Cho WY; Yau LC; Yau T
    Anticancer Agents Med Chem; 2013 Mar; 13(3):382-8. PubMed ID: 23092266
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Differential methylation of G-protein coupled receptor signaling genes in gastrointestinal neuroendocrine tumors.
    Byun S; Affolter KE; Snow AK; Curtin K; Cannon AR; Cannon-Albright LA; Thota R; Neklason DW
    Sci Rep; 2021 Jun; 11(1):12303. PubMed ID: 34112938
    [TBL] [Abstract][Full Text] [Related]  

  • 18. High VEGF serum values are associated with locoregional spread of gastroenteropancreatic neuroendocrine tumors (GEP-NETs).
    Cigrovski Berković M; Čačev T; Catela Ivković T; Marout J; Ulamec M; Zjačić-Rotkvić V; Kapitanović S
    Mol Cell Endocrinol; 2016 Apr; 425():61-8. PubMed ID: 26805636
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dictating genomic destiny: Epigenetic regulation of pancreatic neuroendocrine tumours.
    Gundara JS; Jamal K; Kurzawinski T
    Mol Cell Endocrinol; 2018 Jul; 469():85-91. PubMed ID: 28385665
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Genes involved in neuroendocrine tumor biology.
    Hofsli E
    Pituitary; 2006; 9(3):165-78. PubMed ID: 17001466
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.